bnp paribas high yield conference - cegedim · 15-01-2015 · significantly negative currency...
TRANSCRIPT
-
BNP Paribas High Yield Conference
15 January 2015
-
Safe Harbor Statement
This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the company's judgment regarding future events, and are based on currently available information. Consequently the company cannot guarantee their accuracy and their completeness, and actual results may differ materially from those the company anticipated due to a number of uncertainties, many of which the company is not aware of. For additional information concerning these and other important factors that may cause the company's actual results to differ materially from expectations and underlying assumptions, please refer to the reports filed by the company with the ‘Autorité des Marchés Financiers’.
-
Cegedim Group Activities
Financial Performance
Agenda
-
Cegedim Group Activities
-
5 This document should not be distributed without Cegedim authorization – Copyright 2014
Cegedim Today
-
6 This document should not be distributed without Cegedim authorization – Copyright 2014
Two Different Strategies
-
7 This document should not be distributed without Cegedim authorization – Copyright 2014
Two Different Strategies
-
8 This document should not be distributed without Cegedim authorization – Copyright 2014
Definitive Purchase Agreement Executed
-
9 This document should not be distributed without Cegedim authorization – Copyright 2014
Next Steps on IMS Health Transaction
-
10 This document should not be distributed without Cegedim authorization – Copyright 2014
IMS Health Transaction: FAQ
-
11 This document should not be distributed without Cegedim authorization – Copyright 2014
Two Different Strategies
-
12 This document should not be distributed without Cegedim authorization – Copyright 2014
Based on FY 2013 proforma figures
New Cegedim: Key Proforma Figures
-
13 This document should not be distributed without Cegedim authorization – Copyright 2014
Based on FY 2013 proforma figures
Healthcare Professionals Division
-
14 This document should not be distributed without Cegedim authorization – Copyright 2014
Based on 2013 figures
Cegedim Healthcare Software
-
15 This document should not be distributed without Cegedim authorization – Copyright 2014
Based on FY 2013 proforma figures
Insurance & Services Division
-
16 This document should not be distributed without Cegedim authorization – Copyright 2014
Based on 2013 figures
Cegedim Assurances
-
17 This document should not be distributed without Cegedim authorization – Copyright 2014
Cegedim SRH
-
18 This document should not be distributed without Cegedim authorization – Copyright 2014
Cegedim e-business
-
19 This document should not be distributed without Cegedim authorization – Copyright 2014
Based on FY 2013 proforma figures
GERS Activities & Reconciliation Division
-
20 This document should not be distributed without Cegedim authorization – Copyright 2014
Seismic Changes in Healthcare
-
21 This document should not be distributed without Cegedim authorization – Copyright 2014
Cegedim Will Remain on Attractive Markets
-
Cegedim Strengths
22 This document should not be distributed without Cegedim authorization – Copyright 2014
-
Financial Performance
-
24 This document should not be distributed without Cegedim authorization – Copyright 2014
Seasonality and Currency Impact on Business
-
25 This document should not be distributed without Cegedim authorization – Copyright 2014
9M-2014 Balance Sheet
-
26 This document should not be distributed without Cegedim authorization – Copyright 2014
New Cegedim Proforma Capex
-
27 This document should not be distributed without Cegedim authorization – Copyright 2014
Debt Situation
-
28 This document should not be distributed without Cegedim authorization – Copyright 2014
9M-2014 Figures
-
29 This document should not be distributed without Cegedim authorization – Copyright 2014
FY 2014 Outlook
-
30 This document should not be distributed without Cegedim authorization – Copyright 2014
Next Events
-
31 This document should not be distributed without Cegedim authorization – Copyright 2014
2015 Financial Agenda
-
Our IR App is now available
32 This document should not be distributed without Cegedim authorization – Copyright 2014
-
First Nine Months 2014 Financial Situation
-
34 This document should not be distributed without Cegedim authorization – Copyright 2014
First 9M 2014 Takeaways
-
35 This document should not be distributed without Cegedim authorization – Copyright 2014
CRM & Strategic Data Review
Significantly negative currency impact Positive impact on EBITDA from:
• Compliance activities
• OneKey database-related products
Improvement of Profitability of market research activity improved during the first 9 months
-
36 This document should not be distributed without Cegedim authorization – Copyright 2014
Healthcare Professionals Review
• Less demanding comparison level for UK doctors software
• Margin improvement in software for pharmacists activity in France in Q3
• Robust growth in France in products for paramedical professions (nurses, etc.)
• Positive development of RNP activity
-
37 This document should not be distributed without Cegedim authorization – Copyright 2014
Insurance & Services Review
• Transition from a perpetual license model to a SaaS model at Cegedim Global Payments
• Significant investment in Kadrige
• Profitability increase thanks to:
• Activity for Health Insurance companies
• Cegedim SRH
-
38 This document should not be distributed without Cegedim authorization – Copyright 2014
GERS Activities & Reconciliation Review
Favorable trend in EBITDA reflects the virtual stability of corporate costs and the gradual return to breakeven at GERS activities
-
39 This document should not be distributed without Cegedim authorization – Copyright 2014
From Revenue to EBITDA
-
40 This document should not be distributed without Cegedim authorization – Copyright 2014
From EBITDA to EBIT
-
41 This document should not be distributed without Cegedim authorization – Copyright 2014
From EBIT to Net Profit
-
42 This document should not be distributed without Cegedim authorization – Copyright 2014
Net Debt Trend
-
Thank you. We welcome your questions and comments
Jan Eryk UMIASTOWSKI Chief Investment Officer
Head of Investor Relations
[email protected] www.cegedim.com/finance
TEL: +33 (0) 1 49 09 33 36
Diapositive numéro 1Safe Harbor StatementAgendaCegedim Group ActivitiesDiapositive numéro 5Diapositive numéro 6Diapositive numéro 7Diapositive numéro 8Diapositive numéro 9Diapositive numéro 10Diapositive numéro 11Diapositive numéro 12Diapositive numéro 13Diapositive numéro 14Diapositive numéro 15Diapositive numéro 16Diapositive numéro 17Diapositive numéro 18Diapositive numéro 19Diapositive numéro 20Diapositive numéro 21Cegedim StrengthsFinancial PerformanceDiapositive numéro 24Diapositive numéro 25Diapositive numéro 26Diapositive numéro 27Diapositive numéro 28Diapositive numéro 29Diapositive numéro 30Diapositive numéro 31Our IR App is now available First Nine Months 2014�Financial SituationDiapositive numéro 34Diapositive numéro 35Diapositive numéro 36Diapositive numéro 37Diapositive numéro 38Diapositive numéro 39Diapositive numéro 40Diapositive numéro 41Diapositive numéro 42Diapositive numéro 43